Real-World Safety and Efficacy of Glycopyrronium Bromide in Japanese Patients with COPD: A 52-Week Post-Marketing Surveillance

OBJECTIVE: To evaluate the long-term safety and efficacy of glycopyrronium (GLY) in patients with COPD in a real-world setting in Japan. METHODS: This 52-week, multicentre, post-marketing surveillance conducted in Japan, between February 2013 and August 2019, included patients using GLY for the firs...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Chihiro, Wang, Dong, Nakamura, Noriko, Sasajima, Takayoshi, Yoshisue, Hajime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10156031/
https://www.ncbi.nlm.nih.gov/pubmed/37273944
http://dx.doi.org/10.2174/18743064-v16-e2112240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10156031/
https://www.ncbi.nlm.nih.gov/pubmed/37273944
http://dx.doi.org/10.2174/18743064-v16-e2112240

Ejemplares similares